The News Review:

- Current developments in clinical research in India
- ICR UK ties up with ISCR
- Emerging Trends in EDC
- Rohit Katial MD Consultant for the ABC News nCall+ Allergy Center
- University of Arizona College of Medicine Ariz.
- Translational research work has patented the first experimental…

Current developments in clinical research in India
Express Pharma – Dec 31, 2007
expresspharmaonline. From being an import dependent industry in the 1950s the industry has achieved self-sufficiency and gained global recognition as a producer of low cost high quality bulk drugs and formulations. Having proved its mettle in the international market India is now on the helm of taking up the challenge of proving its efficiency as the capital for global clinical trials. Numbers of factors favour the recognition of India as a hub for clinical research due to which the multinational companies have identified it as their ideal destination. Firstly there are numerous government funded medical and pharmaceutical institutions having state-of-the-art facilities which can serve as ideal centres for multi-centred clinical trials.

ICR UK ties up with ISCR
Express Pharma – Dec 31, 2007
The ICR Chairperson Susan llier and CE Dr John Hooper were recently in India to finalise the agreement. "ICR is delighted to be able to support the booming pharma market in India which will have a big share of international clinical trials. There is much to be done and we can assist through sharing knowledge and raising standards as we have for the last 30 years internationally and develop professionals in India" says Hooper. Explaining the rationale for the tie up Dr Suresh Menon President ISCR says "ICR is a global brand recognised as a pioneer in the field of clinical research training… Hussain is currently in the process of establishing an ICR office in Hyderabad which will be functional by January 2008. This will also be the base for the University of Manchester UK which has developed an extensive range of individual modules which can lead to an MSc in clinical research for those who cannot or choose not to attend a conventional classroom course. The Global Institute of Clinical Research was established 30 years ago and is a membership organisation of clinical research individuals at varying stages of their career and recognised through the class of membership starting at Affiliate to Registered to Professional Member Chartered Scientist and Fellow. The Institute is governed by a Board of Directors elected by the membership and managed by a professional team that provides support in education training programmes conferences workshops and seminars. It has an extensive information service online with searchable databases online e-learning programmes and provides special interest groups to meet the interests and topics in clinical research. For example the groups include pharmacy medical devices paediatrics etc. The institute has a continuing professional development scheme to ensure all members can keep up to date develop professional standards and it produces publications including its journal CRfocus.

Emerging Trends in EDC
Express Pharma – Dec 31, 2007
medical history medical procedures prescribed medications vital signs) needed for the trial will already be available in an electronic form through the EHR the introduction of the clinical research processes in EHR systems and processes will extend and accelerate the existing benefits of EDC into an increasing number of clinical trials and an increasing number of hospitals and healthcare clinics. Avoid duplicate tasks that increase cost of clinical research (thus increasing costs for marketed medications)— Significant benefits can be accrued through collaboration of both the healthcare and research worlds by effectively and efficiently sharing data. Without such collaboration and as the use of EHRs grows both the healthcare sector and bio-pharmaceutical companies will be obliged to spend valuable resources on duplicate tasks increasing the overall cost of clinical research and its product. Benefits to patients All patients whose healthcare provider participates in a nationwide EHR system will reap benefits of that system facilitating clinical research.

Rohit Katial MD Consultant for the ABC News nCall+ Allergy Center
ABC News – Dec 31, 2007
National Jewish Medical and Research Center (ABCNEWS. com)He is currently a full-time staff physician and professor in the department of medicine at National Jewish Medical and Research Center and at the University of Colorado Health Sciences Center. He serves in multiple roles: he is the program director for the Allergy and Immunology Fellowship Program and also the director of the Weinberg Clinical Research Unit. Additionally he is the vice president of the Colorado Allergy Society.

University of Arizona College of Medicine Ariz.
ABC News – Dec 31, 2007
ur first mission is to educate patients in improving their lives and understanding better their disease and the therapies which are offered to them. In improving the way they relate to their own bodies and essentially having a better outcome for their lives as a whole. This knowledge comes from knowledge we have from creating in a very vital environment which goes from anywhere from basic bench research to clinical research. We are committed to becoming a center of absolute excellence worldwide in some of the areas which are already very fertile and vital within our own center.

Translational research work has patented the first experimental…
innovations report – Dec 31, 2007
CSIC has patented as a treatment the cell suspension transplanted with this innovative strategy. The world patent will be proved in humans with a clinical study soon conducted in the Hospital Cl?c de Barcelona thanks to the financing of the Fundaci?enoma Espa?nd CSIC This study will have the participation of 6 recently diagnosed patients who will receive a suspension of type II pneumocytes coming from a dead donor since these cells cannot be cultured in the laboratory. All this events throw new and hopeful light into basic and clinical research lines. ne of the following steps of researchers will be to try to obtain type II pneumocytes from adult stem cells. ex Argem?aburit | Quelle:.